Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca's Lynparza Slows Breast Cancer Caused By BRCA Mutations By 42%
AstraZeneca's Lynparza Slows Breast Cancer Caused By BRCA Mutations By 42%
AstraZeneca's Lynparza Slows Breast Cancer Caused By BRCA Mutations By 42%
Submitted by
admin
on June 4, 2017 - 11:53am
Source:
Forbes
News Tags:
AstraZeneca
Lynparza
breast cancer
BRCA-mutant breast cancer
ASCO 2017
Headline:
AstraZeneca's Lynparza Slows Breast Cancer Caused By BRCA Mutations By 42%
Do Not Allow Advertisers to Use My Personal information
